If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kentaro Tanaka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Cytokines Medicine & Life Sciences
Regulatory T-Lymphocytes Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Helper-Inducer T-Lymphocytes Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Th17 Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2019

  • 1262 Citations
  • 13 h-Index
  • 32 Article
  • 3 Letter
  • 1 Review article

Identification of genomic alterations acquired during treatment with EGFR-TKIs in non-small cell lung cancer

Kubo, N., Harada, T., Shiraishi, Y., Nosaki, K., Nakagaki, N., Takeshita, M., Ouchi, H., Iwama, E., Tanaka, K., Okamoto, I., Sasaki, H. & Nakanishi, Y., Feb 1 2019, In : Anticancer research. 39, 2, p. 671-677 7 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Therapeutics
Exome

Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer

Udagawa, H., Akamatsu, H., Tanaka, K., Takeda, M., Kanda, S., Kirita, K., Teraoka, S., Nakagawa, K., Fujiwara, Y., Yasuda, I., Okubo, S., Shintani, M., Kosloski, M. P., Scripture, C., Tamura, T. & Okamoto, I., Sep 1 2019, In : Lung Cancer. 135, p. 145-150 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Pharmacokinetics
Safety
Hypoalbuminemia
Retreatment
1 Citation (Scopus)

Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies

Yoneshima, Y., Tanaka, K., Shiraishi, Y., Hata, K., Watanabe, H., Harada, T., Otsubo, K., Iwama, E., Inoue, H., Masuda, S., Nakanishi, Y. & Okamoto, I., Apr 1 2019, In : Lung Cancer. 130, p. 5-9 5 p.

Research output: Contribution to journalArticle

Antinuclear Antibodies
Non-Small Cell Lung Carcinoma
Safety
Autoimmune Diseases
Disease-Free Survival

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Akamatsu, H., Ninomiya, K., Kenmotsu, H., Morise, M., Daga, H., Goto, Y., Kozuki, T., Miura, S., Sasaki, T., Tamiya, A., Teraoka, S., Tsubata, Y., Yoshioka, H., Hattori, Y., Imamura, C. K., Katsuya, Y., Matsui, R., Minegishi, Y., Mizugaki, H., Nosaki, K. & 13 others, Okuma, Y., Sakamoto, S., Sone, T., Tanaka, K., Umemura, S., Yamanaka, T., Amano, S., Hasegawa, K., Morita, S., Nakajima, K., Maemondo, M., Seto, T. & Yamamoto, N., Jul 12 2019, In : International Journal of Clinical Oncology. 24, 7, p. 731-770 40 p.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Guidelines
Japan
Patient Advocacy

Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patients

Anai, S., Iwama, E., Yoneshima, Y., Otsubo, K., Tanaka, K., Nakanishi, Y. & Okamoto, I., Dec 1 2018, In : Lung Cancer. 126, p. 156-161 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Platinum
Alleles
irinotecan